Seung-Bin Park

468 total citations
9 papers, 406 citations indexed

About

Seung-Bin Park is a scholar working on Immunology, Pharmacology and Immunology and Allergy. According to data from OpenAlex, Seung-Bin Park has authored 9 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Pharmacology and 3 papers in Immunology and Allergy. Recurrent topics in Seung-Bin Park's work include Mast cells and histamine (5 papers), Allergic Rhinitis and Sensitization (3 papers) and Urticaria and Related Conditions (2 papers). Seung-Bin Park is often cited by papers focused on Mast cells and histamine (5 papers), Allergic Rhinitis and Sensitization (3 papers) and Urticaria and Related Conditions (2 papers). Seung-Bin Park collaborates with scholars based in South Korea and United States. Seung-Bin Park's co-authors include Sang‐Hyun Kim, Taeg Kyu Kwon, Mi-Sun Kim, Hwa–Young Son, Soyoung Lee, Eun‐Ju Choi, Jeoung‐Hee Ha, Yeo Hyang Kim, Jung‐Eun Kim and Maan‐Gee Lee and has published in prestigious journals such as Food and Chemical Toxicology, Experimental Biology and Medicine and Frontiers in Pharmacology.

In The Last Decade

Seung-Bin Park

9 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seung-Bin Park South Korea 7 111 91 89 84 57 9 406
Guang Hai Yan China 14 184 1.7× 134 1.5× 71 0.8× 36 0.4× 67 1.2× 19 519
Satomi Yano Japan 10 127 1.1× 86 0.9× 27 0.3× 136 1.6× 66 1.2× 12 514
Hui‐Seong Kim South Korea 12 191 1.7× 72 0.8× 128 1.4× 36 0.4× 26 0.5× 18 497
Eun‐Ji Joung South Korea 17 198 1.8× 98 1.1× 82 0.9× 61 0.7× 10 0.2× 20 564
Seung Il Jeong South Korea 12 177 1.6× 36 0.4× 90 1.0× 57 0.7× 18 0.3× 19 397
Miaw‐Ling Chen Taiwan 10 120 1.1× 36 0.4× 104 1.2× 30 0.4× 25 0.4× 14 411
Giciane Carvalho Vieira Brazil 13 82 0.7× 30 0.3× 66 0.7× 24 0.3× 34 0.6× 21 318
Eun‐Hwa Sohn South Korea 16 411 3.7× 78 0.9× 143 1.6× 72 0.9× 25 0.4× 45 774
Young-Bae Seo South Korea 12 181 1.6× 28 0.3× 62 0.7× 36 0.4× 18 0.3× 41 417
Jingyuan Wei China 9 279 2.5× 104 1.1× 129 1.4× 34 0.4× 19 0.3× 11 609

Countries citing papers authored by Seung-Bin Park

Since Specialization
Citations

This map shows the geographic impact of Seung-Bin Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seung-Bin Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seung-Bin Park more than expected).

Fields of papers citing papers by Seung-Bin Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seung-Bin Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seung-Bin Park. The network helps show where Seung-Bin Park may publish in the future.

Co-authorship network of co-authors of Seung-Bin Park

This figure shows the co-authorship network connecting the top 25 collaborators of Seung-Bin Park. A scholar is included among the top collaborators of Seung-Bin Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seung-Bin Park. Seung-Bin Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kim, Yesul, et al.. (2022). TMI-1, TNF-α-Converting Enzyme Inhibitor, Protects Against Paclitaxel-Induced Neurotoxicity in the DRG Neuronal Cells In Vitro. Frontiers in Pharmacology. 13. 842779–842779. 5 indexed citations
2.
Park, Seung-Bin, Soyoung Lee, Hui-Hun Kim, et al.. (2011). Suppression of mast-cell-mediated allergic inflammation byLindera obtusiloba. Experimental Biology and Medicine. 236(2). 240–246. 13 indexed citations
3.
Shin, Tae‐Yong, Seung-Bin Park, In Kyeom Kim, et al.. (2010). Anti-allergic inflammatory activity of the fruit of Prunus persica: Role of calcium and NF-κB. Food and Chemical Toxicology. 48(10). 2797–2802. 25 indexed citations
4.
Park, Seung-Bin, Sang‐Hyun Kim, Kyoungho Suk, et al.. (2010). Clinopodium gracile inhibits mast cell-mediated allergic inflammation: involvement of calcium and nuclear factor-κB. Experimental Biology and Medicine. 235(5). 606–613. 9 indexed citations
5.
Son, Hwa–Young, Soyoung Lee, Seung-Bin Park, et al.. (2009). Toxic effects of mercuric sulfide on immune organs in mice. Immunopharmacology and Immunotoxicology. 32(2). 277–283. 16 indexed citations
6.
Park, Ji‐Yeon, et al.. (2009). 황산을 이용한 열대작물 오일의 전처리 반응 최적화 및 바이오디젤 생산. Korean Journal of Chemical Engineering. 47(6). 762–767. 5 indexed citations
8.
Lee, Soyoung, Hwa–Young Son, Seung-Bin Park, et al.. (2008). Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Archives of Pharmacal Research. 31(10). 1303–1311. 280 indexed citations
9.
Kim, Sang Hyun, Seung-Bin Park, Hoon Jeon, et al.. (2008). Anti-allergic effects of Teucrium japonicum on mast cell-mediated allergy model. Food and Chemical Toxicology. 47(2). 398–403. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026